77.2 F
New York
HomeMedicine

Medicine

CorpAcq and Churchill Capital Corp VII Provide an Update on Proposed Financing to Support Business Combination

Expected Financing Would De-Risk Closing of Business Combination and is Anticipated to Support CorpAcq's Future GrowthNEW YORK and ALTRINCHAM, England, Aug. 2, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and...

Promote Safe Sharps Disposal This Back-to-School Season

Guidance to help students thrive this school yearMISSION, Kan., Aug. 2, 2024 /PRNewswire/ -- (Family Features) Going back to school means new classes, new supplies, new friends and sometimes even new schools – all of which can be overwhelming. The annual back-to-school routine takes...

Leading Medical Claims Management provider, Medlogix, LLC Announces the Acquisition of ReviewWorks

HAMILTON, N.J., July 8, 2024 /PRNewswire/ -- Medlogix, LLC, a leading, national medical claims management solutions provider, announced today that it has acquired Michigan-based ReviewWorks, a premier provider of medical cost containment solutions and disability management services. "ReviewWorks has done a phenomenal job of delivering...

Youth Inventors Compete at The Henry Ford during RTX Invention Convention U.S. Nationals June 5-7, 2024, in Dearborn, Michigan

DEARBORN, Mich., July 8, 2024 /PRNewswire/ -- The Henry Ford hosted over 435 youth inventors from across the country at the ninth annual RTX Invention Convention U.S. Nationals June 5-7, 2024. In addition to competing, participants had the opportunity to pitch their inventions to the...

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

BOSTON, July 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, August 8, 2024. The Company will hold a conference call with investors and analysts...

ESSA Pharma to Present at the JonesHealthcare Seaside Summit

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 8, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will present at...
- Advertising -Miami clinic
- Advertising -Medicine clinic Kiev